nifedipine has been researched along with Leukemia P388 in 3 studies
Nifedipine: A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure.
Leukemia P388: An experimental lymphocytic leukemia originally induced in DBA/2 mice by painting with methylcholanthrene.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kessel, D | 2 |
| Wilberding, C | 1 |
| Shinoda, H | 1 |
| Inaba, M | 1 |
| Tsuruo, T | 1 |
3 other studies available for nifedipine and Leukemia P388
| Article | Year |
|---|---|
Mode of action of calcium antagonists which alter anthracycline resistance.
Topics: Animals; Antibiotics, Antineoplastic; Biological Transport; Calcium Channel Blockers; Cell Line; Dau | 1984 |
In vivo circumvention of vincristine resistance in mice with P388 leukemia using a novel compound, AHC-52.
Topics: Animals; Dihydropyridines; Drug Resistance; Drug Synergism; Female; Leukemia P388; Leukemia, Experim | 1989 |
Interactions among membrane transport systems: anthracyclines, calcium antagonists and anti-estrogens.
Topics: Animals; Antibiotics, Antineoplastic; Biological Transport; Calcium Channel Blockers; Daunorubicin; | 1986 |